Wednesday, 4 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Credit Rating

Sahajanand Medical Technologies Credit Rating

CRISIL has upgraded Sahajanand Medical Technologies' long-term bank facility rating to CRISIL A-/Stable from BBB+/Stable. The upgrade reflects improved business risk, growing scale, and sustained profitability across its global stent manufacturing operations.

Key figures
Value₹300.0 Cr
Source

BSE filing, NSE: SMT. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Sahajanand Medical Technologies Ltd: key numbers

Share price
₹482.85
Market cap
₹4,908 Cr
Revenue (annual)
₹1,210 Cr
Net profit (annual)
₹65.28 Cr
Promoter holding
36.20%
FII holding
35.09%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Sahajanand Medical Technologies Ltd

All →

Other credit rating announcements

All →